Amanote Research
Register
Sign In
THU0203 Changes in C-Reactive Protein and Lipid Levels in Patients With Rheumatoid Arthritis Treated With Abt-494, a Selective Jak-1 Inhibitor
doi 10.1136/annrheumdis-2017-eular.2807
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
M Nurmohamed
Y Zhang
J Lin
H Camp
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
SAT0236 Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral Jak-1 Inhibitor in Patients With Rheumatoid Arthritis in an Open Label Extension Study
Lipid Profile Changes in Patients With Rheumatoid Arthritis and Autoimmune Thyroiditis
Health of Society
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Serum ADA and C-Reactive Protein in Rheumatoid Arthritis
International Journal of Human Genetics
Genetics
Correlation of Immunoglobulin and C Reactive Protein Levels in Ankylosing Spondylitis and Rheumatoid Arthritis.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Lipid Metabolism Disorders in Patients With Rheumatoid Arthritis
Serum Fetuin-A Levels in Patients With Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Correlation of Serum Uric Acid With Disease Activity and C-Reactive Protein in Patients Suffering From Rheumatoid Arthritis
Open Journal of Rheumatology and Autoimmune Diseases
Radiographic Progression According to Baseline C-Reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Patients Treated With Tofacitinib or Adalimumab
Journal of Rheumatology
Rheumatology
Allergy
Immunology
